ROCKWELL MEDICAL, INC. Lease, Cost
ROCKWELL MEDICAL, INC. (RMTI) reported Lease, Cost of $691.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. lease, cost for the quarter ending 2026-06-30 was $691.00K, a 12.53% decline year-over-year.
- ROCKWELL MEDICAL, INC. lease, cost for the quarter ending 2026-03-31 was $712.00K, a 1.25% decline year-over-year.
- ROCKWELL MEDICAL, INC. lease, cost for the quarter ending 2025-12-31 was $741.00K, a 1.65% increase year-over-year.
- ROCKWELL MEDICAL, INC. lease, cost for the quarter ending 2025-09-30 was $753.00K, a 5.17% increase year-over-year.
- ROCKWELL MEDICAL, INC. lease, cost for fiscal 2025 was $3.00M, a 6.94% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. lease, cost for fiscal 2024 was $2.81M, a 3.04% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. lease, cost for fiscal 2023 was $2.90M, a 1.36% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. lease, cost for fiscal 2022 was $2.86M, a 10.17% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $691.00K 10-Q · filed 2026-08-13 | $1.40M 10-Q · filed 2026-08-13 | $2.14M derived: sum of 3 quarters · filed 2026-08-13 | $2.90M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $712.00K 10-Q · filed 2026-05-07 | $1.45M derived: sum of 2 quarters · filed 2026-05-07 | $2.21M derived: sum of 3 quarters · filed 2026-05-07 | $3.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.49M derived: sum of 2 quarters · filed 2026-03-26 | $2.28M derived: sum of 3 quarters · filed 2026-08-13 | $3.00M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $753.00K 10-Q · filed 2025-11-12 | $1.54M derived: sum of 2 quarters · filed 2026-08-13 | $2.26M 10-Q · filed 2025-11-12 | $2.99M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $790.00K 10-Q · filed 2026-08-13 | $1.51M 10-Q · filed 2026-08-13 | $2.24M derived: sum of 3 quarters · filed 2026-08-13 | $2.96M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $721.00K 10-Q · filed 2026-05-07 | $1.45M derived: sum of 2 quarters · filed 2026-05-07 | $2.17M derived: sum of 3 quarters · filed 2026-05-07 | $2.81M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.45M derived: sum of 2 quarters · filed 2026-03-26 | $2.09M derived: sum of 3 quarters · filed 2026-03-26 | $2.81M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $716.00K 10-Q · filed 2025-11-12 | $1.36M derived: sum of 2 quarters · filed 2025-11-12 | $2.08M 10-Q · filed 2025-11-12 | $2.81M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $645.00K 10-Q · filed 2025-08-14 | $1.36M 10-Q · filed 2025-08-14 | $2.10M derived: sum of 3 quarters · filed 2025-08-14 | $2.81M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $720.00K 10-Q · filed 2025-05-12 | $1.45M derived: sum of 2 quarters · filed 2025-05-12 | $2.17M derived: sum of 3 quarters · filed 2025-05-12 | $2.92M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.45M derived: sum of 2 quarters · filed 2025-03-20 | $2.19M derived: sum of 3 quarters · filed 2025-03-20 | $2.90M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $716.00K 10-Q · filed 2024-11-12 | $1.46M derived: sum of 2 quarters · filed 2024-11-12 | $2.17M 10-Q · filed 2024-11-12 | $2.88M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $747.00K 10-Q · filed 2024-08-08 | $1.45M 10-Q · filed 2024-08-08 | $2.16M derived: sum of 3 quarters · filed 2024-08-08 | $2.86M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $703.00K 10-Q · filed 2024-05-14 | $1.41M derived: sum of 2 quarters · filed 2024-05-14 | $2.11M derived: sum of 3 quarters · filed 2024-05-14 | $2.83M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.41M derived: sum of 2 quarters · filed 2024-03-21 | $2.12M derived: sum of 3 quarters · filed 2024-03-21 | $2.86M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $701.00K 10-Q · filed 2023-11-14 | $1.41M derived: sum of 2 quarters · filed 2023-11-14 | $2.15M 10-Q · filed 2023-11-14 | $2.90M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $713.00K 10-Q · filed 2023-08-14 | $1.45M 10-Q · filed 2023-08-14 | $2.20M derived: sum of 3 quarters · filed 2023-08-14 | $2.85M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $736.00K 10-Q · filed 2023-05-15 | $1.49M derived: sum of 2 quarters · filed 2023-05-15 | $2.13M derived: sum of 3 quarters · filed 2023-05-15 | $2.75M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.40M derived: sum of 2 quarters · filed 2023-03-30 | $2.01M derived: sum of 3 quarters · filed 2023-03-30 | $2.60M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $650.00K 10-Q · filed 2022-11-14 | $1.26M derived: sum of 2 quarters · filed 2022-11-14 | $1.85M 10-Q · filed 2022-11-14 | $2.34M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $613.00K 10-Q · filed 2022-08-15 | $1.20M 10-Q · filed 2022-08-15 | $1.69M derived: sum of 3 quarters · filed 2022-08-15 | $2.17M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $583.00K 10-Q · filed 2022-05-16 | $1.08M derived: sum of 2 quarters · filed 2022-05-16 | $1.55M derived: sum of 3 quarters · filed 2022-05-16 | $2.08M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $970.00K derived: sum of 2 quarters · filed 2022-04-08 | $1.50M derived: sum of 3 quarters · filed 2022-04-08 | $2.14M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $476.00K 10-Q · filed 2021-11-15 | $1.01M derived: sum of 2 quarters · filed 2021-11-15 | $1.64M 10-Q · filed 2021-11-15 | $2.19M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $530.00K 10-Q · filed 2021-08-16 | $530.10K 10-Q · filed 2020-08-10 | $1.17M 10-Q · filed 2021-08-16 | $1.17M 10-Q · filed 2020-08-10 | $1.72M derived: sum of 3 quarters · filed 2021-08-16 | $2.34M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $636.00K 10-Q · filed 2021-05-17 | $636.27K 10-Q · filed 2020-05-11 | $1.19M derived: sum of 2 quarters · filed 2021-05-17 | $1.81M derived: sum of 3 quarters · filed 2021-05-17 | $2.45M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.18M derived: sum of 2 quarters · filed 2021-03-31 | $1.81M derived: sum of 3 quarters · filed 2021-03-31 | $2.41M 10-K · filed 2021-03-31 | $2.41M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $626.00K 10-Q · filed 2020-11-09 | $626.28K 10-Q · filed 2019-11-12 | $1.26M derived: sum of 2 quarters · filed 2020-11-09 | $1.86M 10-Q · filed 2020-11-09 | $1.86M 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $637.28K 10-Q · filed 2020-08-10 | $1.27M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $629.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |